tirzepatide kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Tirzepatide for Stage 3 Kidney

In the UK, in March 2023, the National Institute for Health and Care Excellence recommended use of semaglutide injections for weight management on the NHS

The first Phase 3 results came from the TRIUMPH-4 trial, announced in December

However, the raw materials used in the compounded forms may differ from those produced for Novo Nordisk and Lilly, said GLP-1 co-inventor Jens Juul Holst, of the University of Copenhagen, adding that care must be taken in drug production lest it cause potentially harmful immune reactions

he must have had 2 bullet points of how to resistance train in any one of his classes It was chronic disease management, health, clinical application Right after undergrad, he went to Appalachian State University to get a Masters degree under Dr

Important context: these are different regulatory categories